Literature DB >> 30428346

Brd4's Bromodomains Mediate Histone H3 Acetylation and Chromatin Remodeling in Pluripotent Cells through P300 and Brg1.

Tao Wu1, Yasunao F Kamikawa1, Mary E Donohoe2.   

Abstract

The pluripotent state of embryonic stem cells (ESCs) is defined by its transcriptome and epigenome. The chromatin reader Brd4 determines ESC identity. Although Brd4 regulation in gene transcription has been well described, its contribution to the chromatin landscape is less known. Here, we show that Brd4's bromodomains partner with the histone acetyltransferase P300, increasing its enzymatic activities. Augmenting histone acetylation by Brd4-P300 interaction recruits the chromatin remodeler Brg1 altering chromatin structure. This pathway is important for maintaining the expression and chromatin patterns of pluripotency-associated genes, such as Oct4, Nanog, and the X chromosome regulatory long noncoding RNAs Tsix and Xite. Furthermore, we show that the Brd4-P300 interaction regulates the de novo formation of chromatin marks during ESC differentiation, as exemplified by controlling the master regulators of mesoderm formation. Collectively, we delineate the function of Brd4 in organizing the chromatin structure that contributes to gene transcriptional regulation and cell fate determination.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BRD4; Brg1; Oct4; P300; X-chromosome inactivation; acetylation; bromodomains; chromatin; embryonic stem cells; pluripotency

Year:  2018        PMID: 30428346     DOI: 10.1016/j.celrep.2018.10.003

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  30 in total

1.  Interference with the bromodomain epigenome readers drives p21 expression and tumor senescence.

Authors:  Liana P Webber; Veronica Q Yujra; Pablo A Vargas; Manoela D Martins; Cristiane H Squarize; Rogerio M Castilho
Journal:  Cancer Lett       Date:  2019-06-29       Impact factor: 8.679

2.  CN470 is a BET/CBP/p300 multi-bromodomain inhibitor and has an anti-tumor activity against MLL-rearranged acute lymphoblastic leukemia.

Authors:  Natsuki Imayoshi; Makoto Yoshioka; Kuniaki Tanaka; Shyh-Ming Yang; Koshi Akahane; Yuki Toda; Shigekuni Hosogi; Takeshi Inukai; Seiji Okada; David J Maloney; Tatsutoshi Nakahata; Junko Takita; Itaru Kato; Eishi Ashihara
Journal:  Biochem Biophys Res Commun       Date:  2021-12-24       Impact factor: 3.575

Review 3.  Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents.

Authors:  Qingjuan Chen; Binhui Yang; Xiaochen Liu; Xu D Zhang; Lirong Zhang; Tao Liu
Journal:  Theranostics       Date:  2022-06-21       Impact factor: 11.600

4.  Loss of H3K27 Trimethylation Promotes Radiotherapy Resistance in Medulloblastoma and Induces an Actionable Vulnerability to BET Inhibition.

Authors:  Nishanth Gabriel; Kumaresh Balaji; Kay Jayachandran; Matthew Inkman; Jin Zhang; Sonika Dahiya; Michael Goldstein
Journal:  Cancer Res       Date:  2022-05-16       Impact factor: 13.312

5.  Brd4-p300 inhibition downregulates Nox4 and accelerates lung fibrosis resolution in aged mice.

Authors:  Yan Y Sanders; Xing Lyv; Q Jennifer Zhou; Zheyi Xiang; Denise Stanford; Sandeep Bodduluri; Steven M Rowe; Victor J Thannickal
Journal:  JCI Insight       Date:  2020-07-23

Review 6.  BET bromodomains as novel epigenetic targets for brain health and disease.

Authors:  Mandakini B Singh; Gregory C Sartor
Journal:  Neuropharmacology       Date:  2020-09-15       Impact factor: 5.250

7.  Chemical Screen Identifies Diverse and Novel Histone Deacetylase Inhibitors as Repressors of NUT Function: Implications for NUT Carcinoma Pathogenesis and Treatment.

Authors:  Hitoshi Shiota; Artyom A Alekseyenko; Zhipeng A Wang; Ivona Filic; Tatiana M Knox; Nhi M Luong; Yeying Huang; David A Scott; Kristen L Jones; Prafulla C Gokhale; Madeleine E Lemieux; Philip A Cole; Mitzi I Kuroda; Christopher A French
Journal:  Mol Cancer Res       Date:  2021-07-20       Impact factor: 5.852

Review 8.  BET Protein-Mediated Transcriptional Regulation in Heart Failure.

Authors:  Talha Ijaz; Michael A Burke
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 6.208

Review 9.  Low complexity domains, condensates, and stem cell pluripotency.

Authors:  Munender Vodnala; Eun-Bee Choi; Yick W Fong
Journal:  World J Stem Cells       Date:  2021-05-26       Impact factor: 5.326

Review 10.  What do Transcription Factors Interact With?

Authors:  Haining Chen; B Franklin Pugh
Journal:  J Mol Biol       Date:  2021-02-20       Impact factor: 6.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.